| 1 | [SID22403205] | Active | IC50 | 2.207 | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) (2K validation set) [AID504317, Type: confirmatory] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | IC50 | 2.207 [uM] | | BioAssay | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) (2K validation set) | | AID | 504317 | | BioAssay type | confirmatory | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 2 | [SID22403205] | Active | IC50 | 2.798 | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) (2K validation set) [AID504319, Type: confirmatory] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | IC50 | 2.798 [uM] | | BioAssay | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) (2K validation set) | | AID | 504319 | | BioAssay type | confirmatory | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 3 | [SID22403205] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 4 | [SID22403205] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 5 | [SID22403205] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 6 | [SID22403205] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 7 | [SID22403205] | Active | Potency | 12.5893 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 8 | [SID22403205] | Active | Potency | 12.5893 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 9 | [SID22403205] | Active | Potency | 12.5893 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 10 | [SID22403205] | Active | Potency | 12.5893 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 11 | [SID22403205] | Active | Potency | 14.1254 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 12 | [SID22403205] | Active | Potency | 14.1254 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 13 | [SID22403205] | Active | Potency | 16.8336 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 16.8336 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 14 | [SID22403205] | Active | Potency | 16.8336 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 16.8336 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 15 | [SID22403205] | Active | Potency | 16.8336 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 16.8336 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 16 | [SID22403205] | Active | Potency | 16.8336 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 16.8336 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 17 | [SID22403205] | Active | Potency | 17.7828 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 18 | [SID22403205] | Active | IC50 | 27.62 | Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition [AID588689, Type: confirmatory] | Chain A, Crystal Structure Of Dengue-2 Virus Methyltransferase Complexed With S-Adenosyl-L-Homocyste [gi:219689243] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | IC50 | 27.62 [uM] | | BioAssay | Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition | | AID | 588689 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Dengue-2 Virus Methyltransferase Complexed With S-Adenosyl-L-Homocyste [gi:219689243] | | PubMed | | | Data Table |  |
|
| 19 | [SID22403205] | Active | Potency | 28.1838 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 20 | [SID22403205] | Active | Potency | 28.1838 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 21 | [SID22403205] | Active | Potency | 28.1838 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 22 | [SID22403205] | Active | Potency | 31.6228 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 23 | [SID22403205] | Active | Potency | 31.6228 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 24 | [SID22403205] | Active | Potency | 31.6228 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 25 | [SID22403205] | Active | Potency | 31.6228 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 26 | [SID22403205] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 27 | [SID22403205] | Active | | | Leishmania major promastigote HTS [AID1063, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | BioAssay | Leishmania major promastigote HTS | | AID | 1063 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID22403205] | Active | | | Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) [AID493027, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | BioAssay | Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) | | AID | 493027 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 29 | [SID22403205] | Active | | | Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) [AID493035, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Active | | BioAssay | Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) | | AID | 493035 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 30 | [SID22403205] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 31 | [SID22403205] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 32 | [SID22403205] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 33 | [SID22403205] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 34 | [SID22403205] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 35 | [SID22403205] | Inactive | Potency | 31.6228 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 36 | [SID22403205] | Inactive | IC50 | | Discovery of Small Molecule Probes for H1N1 Influenza NS1A [AID504329, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/California/07/2009(H1N1))] [gi:227977143] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Discovery of Small Molecule Probes for H1N1 Influenza NS1A | | AID | 504329 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/California/07/2009(H1N1))] [gi:227977143] | | PubMed | | | Data Table |  |
|
| 37 | [SID22403205] | Inactive | Potency | | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 38 | [SID22403205] | Inactive | Potency | | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) [AID1476, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) | | AID | 1476 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 39 | [SID22403205] | Inactive | Potency | | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) [AID1478, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) | | AID | 1478 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 40 | [SID22403205] | Inactive | Potency | | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2549 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 41 | [SID22403205] | Inactive | Potency | | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1721, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1721 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 42 | [SID22403205] | Inactive | Potency | | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1722, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1722 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 43 | [SID22403205] | Inactive | | | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity [AID504423, Type: screening] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504423 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 44 | [SID22403205] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 45 | [SID22403205] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 46 | [SID22403205] | Inactive | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 47 | [SID22403205] | Inactive | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 48 | [SID22403205] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 49 | [SID22403205] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 50 | [SID22403205] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 22403205 | | CID | 2261569 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|